Enhancing Lung Cancer Screening Uptake Through a Direct-to-Patient Digital Health Intervention: Insights from a Randomized Clinical Trial
Highlight
1. Lung cancer screening with low-dose computed tomography (LDCT) reduces mortality but remains underutilized in the US, with screening rates below 20% among eligible populations.
2. A randomized clinical trial investigating a direct-to-patient digital health program (mPATH-Lung) demonstrated a significant increase in lung cancer screening completion compared to enhanced usual care.
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.